Skip to main content
SpringerLink
Log in
Book cover

Heart Teams for Treatment of Cardiovascular Disease pp 23–34Cite as

Heart Teams for Aortic Valve Disease: The TAVI Revolution

  • Chapter
  • First Online:

  • 520 Accesses

Abstract

Severe aortic valve stenosis is associated with poor prognosis without intervention. Surgical aortic valve replacement was the standard intervention until the advent of transcatheter aortic valve implantation in 2002. The last two decades witnessed a rapid evolution in decision-making, technology and techniques. Concurrently, patients with aortic stenosis are becoming increasingly more complex. A multidisciplinary “Heart Team” facilitates navigation through a complex and continually evolving decision-making environment. This chapter explores the history, composition, role, benefits, challenges, and future of the Heart Team evaluating aortic stenosis in general with specific anecdotes as it applies to the authors’ center: The University of Ottawa Heart Institute (UOHI) in Ottawa, Canada.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. d’Arcy JL, Coffey S, Loudon MA, Kennedy A, Pearson-Stuttard J, Birks J, et al. Large-scale community echocardiographic screening reveals a major burden of undiagnosed valvular heart disease in older people: the OxVALVE Population Cohort Study. Eur Heart J. 2016;37(47):3515–22.

    Article  Google Scholar 

  2. Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. The Tromso study. Heart. 2013;99(6):396–400.

    Article  Google Scholar 

  3. Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013;62(11):1002–12.

    Article  Google Scholar 

  4. Clark MA, Arnold SV, Duhay FG, Thompson AK, Keyes MJ, Svensson LG, et al. Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis. Circ Cardiovasc Qual Outcomes. 2012;5(5):697–704.

    Article  Google Scholar 

  5. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–607.

    Article  CAS  Google Scholar 

  6. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370(19):1790–8.

    Article  CAS  Google Scholar 

  7. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.

    Article  CAS  Google Scholar 

  8. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.

    Article  CAS  Google Scholar 

  9. Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–31.

    Article  Google Scholar 

  10. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Thorac Cardiovasc Surg. 2014;148(1):e1–e132.

    Article  Google Scholar 

  11. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012): the joint task force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42(4):S1–44.

    Article  Google Scholar 

  12. Webb J, Rodés-Cabau J, Fremes S, Pibarot P, Ruel M, Ibrahim R, et al. Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement. Can J Cardiol. 2012;28(5):520–8.

    Article  Google Scholar 

  13. Croke JM, El-Sayed S. Multidisciplinary management of cancer patients: chasing a shadow or real value? An overview of the literature. Curr Oncol. 2012;19(4):e232–8.

    Article  CAS  Google Scholar 

  14. Freeman RK, Van Woerkom JM, Vyverberg A, Ascioti AJ. The effect of a multidisciplinary thoracic malignancy conference on the treatment of patients with lung cancer. Eur J Cardiothorac Surg. 2010;38(1):1–5.

    Article  Google Scholar 

  15. Kesson EM, Allardice GM, George WD, Burns HJ, Morrison DS. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13,722 women. BMJ. 2012;344:e2718.

    Article  Google Scholar 

  16. Taylor C, Munro AJ, Glynne-Jones R, Griffith C, Trevatt P, Richards M, et al. Multidisciplinary team working in cancer: what is the evidence? BMJ. 2010;340:c951.

    Article  Google Scholar 

  17. Del Sindaco D, Pulignano G, Minardi G, Apostoli A, Guerrieri L, Rotoloni M, et al. Two-year outcome of a prospective, controlled study of a disease management programme for elderly patients with heart failure. J Cardiovasc Med (Hagerstown). 2007;8(5):324–9.

    Article  Google Scholar 

  18. Ducharme A, Doyon O, White M, Rouleau JL, Brophy JM. Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial. CMAJ. 2005;173(1):40–5.

    Article  Google Scholar 

  19. Takeda A, Taylor SJ, Taylor RS, Khan F, Krum H, Underwood M. Clinical service organisation for heart failure. Cochrane Database Syst Rev. 2012;(9):CD002752.

    Google Scholar 

  20. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–72.

    Article  CAS  Google Scholar 

  21. Forcillo J, Condado JF, Ko YA, Yuan M, Binongo JN, Ndubisi NM, et al. Assessment of commonly used frailty markers for high- and extreme-risk patients undergoing transcatheter aortic valve replacement. Ann Thorac Surg. 2017;104(6):1939–46.

    Article  Google Scholar 

  22. Lauck SB, Wood DA, Baumbusch J, Kwon JY, Stub D, Achtem L, et al. Vancouver transcatheter aortic valve replacement clinical pathway: minimalist approach, standardized care, and discharge criteria to reduce length of stay. Circ Cardiovasc Qual Outcomes. 2016;9(3):312–21.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Ottawa Heart Institute, Department of Surgery, Division of Cardiac Surgery, Ottawa, ON, Canada

    Talal Al-Atassi

  2. University of Ottawa Heart Institute, Division of Cardiology, Ottawa, ON, Canada

    Marino Labinaz

Authors
  1. Talal Al-Atassi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marino Labinaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Talal Al-Atassi .

Editor information

Editors and Affiliations

  1. University of Ottawa Heart Institute, Ottawa, ON, Canada

    Thierry Mesana

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Al-Atassi, T., Labinaz, M. (2019). Heart Teams for Aortic Valve Disease: The TAVI Revolution. In: Mesana, T. (eds) Heart Teams for Treatment of Cardiovascular Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-19124-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-19124-5_3

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-19123-8

  • Online ISBN: 978-3-030-19124-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation